EP on EP Episode 86: Update on ARVC with Hugh Calkins, MD, FHRS-EP on EP Episode 86: Update on ARVC with Hugh Calkins, MD, FHRS

EP on EP Episode 86: Update on ARVC with Hugh Calkins, MD, FHRS

Video Transcription

Video Summary

In this video, Dr. Hugh Calkins discusses arrhythmogenic right ventricular cardiomyopathy (ARVC) and its nomenclature. He explains that ARVC is the initial disease that has diagnostic criteria, while arrhythmogenic cardiomyopathy is a broader term that includes various inherited cardiomyopathies. Dr. Calkins also talks about risk scores for ARVC, including one for predicting sustained ventricular arrhythmias and another for predicting ventricular fibrillation and flutter. He highlights the importance of genetic testing in diagnosing ARVC and discusses ongoing research into gene therapy for treating the disease. Lastly, he advises caution in engaging in high-intensity, long-duration exercise for individuals who are gene positive but phenotypically negative for ARVC.

Keywords

Arrhythmogenic right ventricular cardiomyopathy

ARVC

Nomenclature

Genetic testing

Gene therapy